Circulating KL-6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome

Journal of Internal Medicine

Volumn 263, Issue 4, 2008, Pages 432-439

  Nakashima, T ^b   Yokoyama, A ^a   Ohnishi, H ^b   Hamada, H ^c   Ishikawa, N ^b   Haruta, Y ^b   Hattori, N ^b   Tanigawa, K ^b   Kohno, N ^b  

^a KOCHI UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute respiratory distress syndrome; Coagulation; D dimer; KL 6; Mucins; Platelets

Indexed keywords

MUCIN 1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOLYSIS; FOLLOW UP; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL;

AGED; CA-15-3 ANTIGEN; DISSEMINATED INTRAVASCULAR COAGULATION; EARLY DIAGNOSIS; FEMALE; HUMANS; LUNG; MALE; PREDICTIVE VALUE OF TESTS; RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERITY OF ILLNESS INDEX;

EID: 40349088823     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01929.x     Document Type: Article

References (31)

1. Bernard GR. Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med 2005 172 : 798 806.
2. Shih JY, Yang SC, Yu CJ et al. Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997 156 : 1453 7.
3. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989 96 : 68 73.
4. Kohno N, Awaya Y, Oyama T et al. KL-6, a mucin-like glycoprotein in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993 148 : 637 42.
5. Ohnishi H, Yokoyama A, Kondo K et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung disease. Am J Respir Crit Care Med 2002 165 : 378 81.
6. Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med 2006 260 : 429 34.
7. Sato H, Callister ME, Mumby S et al. KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J 2004 23 : 142 5.
8. Ishizaka A, Matsuda T, Albertine KH et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004 286 : L1088 94.
9. Yokoyama A, Kohno N, Hamada H et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998 158 : 1680 4.
10. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000 342 : 1334 49.
11. Welty-Wolf KE, Carraway MS, Ortel TL, Piantadosi CA. Coagulation and inflammation in acute lung injury. Thromb Haemost 2002 88 : 17 25.
12. Abraham E. Coagulation abnormality in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000 22 : 401 4.
13. Bone RC, Francis PB, Pierce AK. Intravascular coagulation associated with the adult respiratory distress syndrome. Am J Med 1976 61 : 585 9.
14. Levi M. Disseminated intravascular coagulation. Crit Care Med 2007 35 : 2191 5.
15. Gando S, Kameue T, Matsuda N et al. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res 2003 109 : 119 24.
16. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 344 : 699 709.
17. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 2003 112 : 853 62.
18. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994 149 : 818 24.
19. Kohno N, Akiyama M, Kyoizumi S et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6 against lung adenocarcinoma. Jpn J Clin Oncol 1988 18 : 203 16.
20. Murray JF, Matthay MA, Luce JM et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988 138 : 720 3.
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985 13 : 818 29.
22. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996 22 : 707 10.
23. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee : American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992 20 : 864 74.
24. Gando S, Iba T, Eguchi Y et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006 34 : 625 31.
25. Gunther A, Mosavi P, Heinemann S et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000 161 : 454 62.
26. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003 31 : S213 20.
27. Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003 31 : S238 42.
28. Idell S, James KK, Levin EG et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989 84 : 695 705.
29. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003 285 : L20 8.
30. Wada H, Wakita Y, Nakase T et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 1995 74 : 848 52.
31. Gando S, Kameue T, Matsuda N, Sawamura A, Hayakawa M, Kato H. Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation 2004 28 : 237 44.